Quarterly report pursuant to Section 13 or 15(d)

Schedule of Stock Option Transactions (Details)

v3.21.2
Schedule of Stock Option Transactions (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Dec. 31, 2019
Equity [Abstract]      
Number of Options, Outstanding Beginning 17,004  
Weighted Average Exercise Price, Outstanding Beginning $ 16.00  
Weighted Average Remaining Contractual Term (Years), Outstanding 5 years 5 months 1 day 6 years 1 month 28 days 0 years
Aggregate Intrinsic Value, Outstanding Beginning  
Number of Options, Exercisable    
Weighted Average Exercise Price, Exercisable Beginning    
Weighted Average Remaining Contractual Term (Years), Exercisable   0 years  
Aggregate Intrinsic Value, Exercisable Beginning    
Number of Options, Vested and Exercisable Beginning  
Weighted Average Exercise Price, Vested and Exercisable Beginning  
Number of Options, Unvested and non-exercisable Beginning 17,004  
Weighted Average Exercise Price, Unvested and non-exercisable Beginning $ 16.00  
Number of Options, Granted 17,004  
Weighted Average Exercise Price, Granted $ 16.00  
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term Granted   7 years  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 8.75  
Number of Options, Exercised  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price  
Number of Options, Cancelled/Forfeited  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price  
Number of Options, Outstanding Ending 17,004 17,004
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance $ 16.00 $ 16.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 3,401
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $ 16.00
Weighted Average Remaining Contractual Term (Years), Vested and Exercisable 5 years 5 months 1 day 0 years  
Number of Options, Unvested and non-exercisable Beginning 13,603 17,004
Weighted Average Exercise Price, Unvested and non-exercisable Beginning $ 16.00 $ 16.00
Weighted Average Remaining Contractual Term (Years), Unvested and non-exercisable 5 years 5 months 1 day 6 years 1 month 28 days